ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MIST Milestone Pharmaceuticals Inc

1.62
0.02 (1.25%)
Last Updated: 12:16:31
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Milestone Pharmaceuticals Inc MIST NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 1.25% 1.62 12:16:31
Open Price Low Price High Price Close Price Previous Close
1.58 1.58 1.71 1.60
more quote information »

Recent News

Date Time Source Heading
3/04/202408:00EDGAR2Form 8-K - Current report
3/01/202415:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202406:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
2/28/202415:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
2/26/202406:06EDGAR2Form 8-K - Current report
2/14/202419:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202406:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/26/202307:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
12/26/202306:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
12/26/202306:15EDGAR2Form 8-K - Current report
11/21/202306:00PRNUSMilestone Pharmaceuticals to Present at the Piper Sandler..
11/13/202306:05EDGAR2Form 8-K - Current report
11/13/202305:57PRNUSMilestone Pharmaceuticals Reports Third Quarter 2023..
11/13/202305:37EDGAR2Form 8-K - Current report
11/13/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202309:00PRNUSMilestone Pharmaceuticals Presents Positive Results from..
11/09/202315:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/07/202308:07EDGAR2Form 8-K - Current report
11/07/202306:00PRNCAMilestone Pharmaceuticals to Host Investor and Analyst..
10/24/202315:05EDGAR2Form 8-K - Current report
10/24/202306:00PRNCAMilestone Pharmaceuticals Announces Submission of New Drug..
10/06/202306:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
9/27/202306:00PRNCAMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
9/05/202306:00PRNCAMilestone Pharmaceuticals to Present at the H.C. Wainwright..
8/10/202306:40EDGAR2Form 8-K - Current report
8/10/202306:35PRNUSMilestone Pharmaceuticals Reports Second Quarter 2023..
8/10/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/20/202306:00PRNCAMilestone Pharmaceuticals Announces Publication of Results..
6/01/202306:00PRNCAMilestone Pharmaceuticals to Present at the Jefferies..
5/22/202306:00PRNUSMilestone Pharmaceuticals Announces Presentation of Data..
5/11/202306:16PRNCAMilestone Pharmaceuticals Reports First Quarter 2023..
5/08/202306:00PRNUSMilestone Pharmaceuticals to Host Virtual Key Opinion Leader..

Your Recent History

Delayed Upgrade Clock